Research Facilities

All of the research activities of UM/Sylvester’s physician-scientists—who conduct breakthrough translational research—are housed on the Miller School of Medicine medical campus.

UM/Sylvester currently has approximately 100,000 square feet of dedicated research space. The Papanicolaou and Batchelor buildings house the program leaders and many of the investigators for three of the four multidisciplinary research programs including the Tumor Immunobiology and Immunotherapy Program, Molecular Targets and Developmental Therapeutics Program, and the Viral Oncology Program.  In addition, the Tumor Bank and several of UM/Sylvester’s shared resources are located here. Meanwhile, the Fox Cancer Research building is home to UM/Sylvester’s administrative offices as well as the Clinical Research Services Office, the Florida Cancer Data System, Information Technology, conference space, and two research laboratories. The newly constructed Clinical Research Building is the home of the Miller School of Medicine’s Clinical and Translational Science Awards or CTSA initiative and houses investigators of UM/Sylvester’s Biobehavioral Oncology and Cancer Epidemiology Program and the Division of Biostatistics, a shared resource of the cancer center. 

The ten-story, 180,000 square foot Biomedical Research Building is under construction across a pedestrian mall from the Fox Cancer Research building. Two floors are allocated to accommodate eight to 10 UM/Sylvester investigators in an open lab configuration. The building is scheduled for completion in the fall of 2008.

The 285,000-square-foot UM/Sylvester, which houses all of the cancer center’s clinical activities, is located on the southwest corner of the medical center campus. The hospital has 40 inpatient beds, an infusion center with 36 stations, four operating rooms, three linear accelerators, out-patient clinics with 100 examination rooms, and a full-service imaging center.  Plans to significantly expand the hospital including the addition of in-patient beds are underway.